These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 1460783)
1. [Serum alpha 1-antichymotrypsin in senile dementia]. Nagao T; Hamamoto M; Hagiwara M; Kanda A; Ichiseki H; Miyazaki T; Isse K; Tanaka K; Ogura M; Tsushima T Nihon Ronen Igakkai Zasshi; 1992 Oct; 29(10):778-82. PubMed ID: 1460783 [TBL] [Abstract][Full Text] [Related]
2. Serum concentration of alpha 1-antichymotrypsin is elevated in patients with senile dementia of the Alzheimer type. Matsubara E; Amari M; Shoji M; Harigaya Y; Yamaguchi H; Okamoto K; Hirai S Prog Clin Biol Res; 1989; 317():707-14. PubMed ID: 2690117 [TBL] [Abstract][Full Text] [Related]
3. Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia. Matsubara E; Hirai S; Amari M; Shoji M; Yamaguchi H; Okamoto K; Ishiguro K; Harigaya Y; Wakabayashi K Ann Neurol; 1990 Oct; 28(4):561-7. PubMed ID: 2147546 [TBL] [Abstract][Full Text] [Related]
4. Serological alpha 1-antichymotrypsin in patients with probable senile dementia of Alzheimer type: a short-term longitudinal study. Licastro F; Davis LJ; Polazzi E; Rossi S; Cucinotta D Alzheimer Dis Assoc Disord; 1996; 10(4):192-6. PubMed ID: 8939278 [TBL] [Abstract][Full Text] [Related]
5. Blood-brain barrier permeability of the demented elderly as studied by cerebrospinal fluid-serum albumin ratio. Wada H Intern Med; 1998 Jun; 37(6):509-13. PubMed ID: 9678683 [TBL] [Abstract][Full Text] [Related]
6. Monomeric and polymeric forms of alpha-1 antichymotrypsin in sera from patients with probable late onset Alzheimer's disease. Licastro F; Sirri V; Trerè D; Davis LJ Dement Geriatr Cogn Disord; 1997; 8(6):337-42. PubMed ID: 9370085 [TBL] [Abstract][Full Text] [Related]
7. Serum alpha 1-antichymotrypsin is not a useful marker for Alzheimer's disease or dementia in Parkinson's disease. Kuiper MA; van Kamp GJ; Bergmans PL; Scheltens P; Wolters EC J Neural Transm Park Dis Dement Sect; 1993; 6(2):145-9. PubMed ID: 8117411 [TBL] [Abstract][Full Text] [Related]
8. Increased chemiluminescence response of neutrophils from the peripheral blood of patients with senile dementia of the Alzheimer's type. Licastro F; Morini MC; Davis LJ; Malpassi P; Cucinotta D; Parente R; Melotti C; Savorani G J Neuroimmunol; 1994 Apr; 51(1):21-6. PubMed ID: 8157733 [TBL] [Abstract][Full Text] [Related]
10. [The significance of measurement of contents of serum serine protease inhibitors in senile dementia of the Alzheimer type]. Amari M; Matsubara E; Ishiguro K; Shoji M; Hirai S Rinsho Shinkeigaku; 1989 Oct; 29(10):1256-60. PubMed ID: 2605832 [TBL] [Abstract][Full Text] [Related]
11. [A follow-up study on the outcome and relevant factors in senile dementia of Alzheimer type and vascular dementia]. Ueki A; Shinjo H; Nakajima T; Miwa C; Morita Y Nihon Ronen Igakkai Zasshi; 1999 May; 36(5):358-64. PubMed ID: 10466354 [TBL] [Abstract][Full Text] [Related]
12. [Epidemiologic and clinico-pathologic study on senile dementia in a Japanese community, Hisayama]. Kawano H Fukuoka Igaku Zasshi; 1993 Jun; 84(6):311-21. PubMed ID: 8335307 [TBL] [Abstract][Full Text] [Related]
13. [Neuropathologic study of 50 cases of senile dementia]. Fallet-Bianco C; Roudier M; Lamour Y; Davous P Rev Neurol (Paris); 1990; 146(11):687-96. PubMed ID: 2077618 [TBL] [Abstract][Full Text] [Related]
14. Changes in blood glucose and insulin secretion in patients with senile dementia of Alzheimer type. Bucht G; Adolfsson R; Lithner F; Winblad B Acta Med Scand; 1983; 213(5):387-92. PubMed ID: 6349261 [TBL] [Abstract][Full Text] [Related]
15. Role of interleukin 6 and alpha-globulins in differentiating Alzheimer and vascular dementias. Helmy AA; Naseer MM; Shafie SE; Nada MA Neurodegener Dis; 2012; 9(2):81-6. PubMed ID: 22133543 [TBL] [Abstract][Full Text] [Related]
16. Increased serum alpha 1-antichymotrypsin in patients with probable Alzheimer's disease: an acute phase reactant without the peripheral acute phase response. Licastro F; Morini MC; Polazzi E; Davis LJ J Neuroimmunol; 1995 Mar; 57(1-2):71-5. PubMed ID: 7535791 [TBL] [Abstract][Full Text] [Related]
17. [Concentrations of multiple neurochemicals in the cerebrospinal fluid of patients with senile dementia and the relationship to alpha 1-antichymotrypsin]. Wada H; Iijima S; Mizoguchi T; Mashige F; Orimo H Nihon Ronen Igakkai Zasshi; 1993 Jan; 30(1):46-53. PubMed ID: 8474228 [TBL] [Abstract][Full Text] [Related]
18. Plasma and cerebrospinal fluid alpha1-antichymotrypsin levels in Alzheimer's disease: correlation with cognitive impairment. DeKosky ST; Ikonomovic MD; Wang X; Farlow M; Wisniewski S; Lopez OL; Becker JT; Saxton J; Klunk WE; Sweet R; Kaufer DI; Kamboh MI Ann Neurol; 2003 Jan; 53(1):81-90. PubMed ID: 12509851 [TBL] [Abstract][Full Text] [Related]
19. Alpha 1-antichymotrypsin is present in diffuse senile plaques. A comparative study of beta-protein and alpha 1-antichymotrypsin immunostaining in the Alzheimer brain. Shoji M; Hirai S; Yamaguchi H; Harigaya Y; Ishiguro K; Matsubara E Am J Pathol; 1991 Jan; 138(1):247-57. PubMed ID: 1702930 [TBL] [Abstract][Full Text] [Related]
20. Relationship between serum alpha 1-antichymotrypsin and Alzheimer's disease. Hinds TR; Kukull WA; Van Belle G; Schellenberg GD; Villacres EC; Larson EB Neurobiol Aging; 1994; 15(1):21-7. PubMed ID: 8159260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]